Reservoir-Based Polymer-Free Amphilimus-Eluting Stent Versus Polymer-Based Everolimus-Eluting Stent in Diabetic Patients

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 112 participants.

Also called NCT01710748

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 112 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01710748
Other papers using this trial's data
  • A Randomized Comparison of Reservoir-Based Polymer-Free Amphilimus-Eluting Stents Versus Everolimus-Eluting Stents With Durable Polymer in Patients With Diabetes Mellitus: The RESERVOIR Clinical Trial JACC. Cardiovascular interventions, 2016-01-11 DOI, PubMed 26762910

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01710748. Randomized; single masking; primary purpose treatment. Start 2012-10 (registry gives no type); primary completion 2014-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Reservoir-Based Polymer-Free Amphilimus-Eluting Stent Versus Polymer-Based Everolimus-Eluting Stent in Diabetic Patients
Acronym
RESERVOIR
Condition
Diabetes Mellitus
Intervention (Device)
Polymer-Based Everolimus-Eluting Stent
Intervention (Device)
Polymer-Free Amphilimus-Eluting Stent
Lead sponsor
Spanish Society of Cardiology (class: other)

Record details

Record id
cardio:ct-nct01710748
Content hash
58ebc5b94c3cfdddc7801f417f43ec72a4bf895062ef40d039bfb7f5faf52796